UDG Healthcare Public Limited Co. Update disclosure of relevant securities in issue (4567C)

TIDMUDG

RNS Number : 4567C

UDG Healthcare Public Limited Co.

18 June 2021

UDG HEALTHCARE PLC

Update disclosure of relevant securities in issue pursuant to Takeover Rule 2.10

18 June, 2021

In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997 Takeover Rules, 2013 ("Takeover Rules"), UDG confirms that it has 251,974,223 ordinary shares of EUR0.05 each ("UDG Ordinary Shares") in issue and admitted to listing on the Official List of the Financial Conduct Authority and to trading on the main market of the London Stock Exchange. This reflects an increase of 43,705 as against the number disclosed on 1 June, 2021 pursuant to Rule 2.10. The ISIN for the UDG Ordinary Shares is IE0033024807.

UDG also confirms that there are 3,270,392 options over ordinary shares outstanding under the Company's share schemes (the 2010 Long Term Incentive Plan and the 2019 Performance Share Plan). This reflects a reduction of 43,705 as against the number disclosed on 1 June, 2021 pursuant to Takeover Rule 2.10.

Contact

Damien Moynagh

General Counsel & Company Secretary

Tel: + 353-1-468-9000

The directors of UDG ("UDG Directors") accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the UDG Directors (who have taken all reasonable care to ensure such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities whether pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions outside Ireland or the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

Any holder of 1% or more of any class of relevant securities of UDG may have disclosure obligations under Rule 8.3 of the Takeover Rules effective from 12 May, 2021, the date of the commencement of the offer period for UDG under the Takeover Rules.

Information in relation to relevant securities in this announcement is as of the close of business on 17 June 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCKZGMVVRZGMZM

(END) Dow Jones Newswires

June 18, 2021 12:54 ET (16:54 GMT)